Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,050
+10 (0.08%)
Sep 12, 2025, 7:48 AM KST

KRX:007570 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
9,7614,2953,4147,1749,28841,341
Short-Term Investments
6,7058,49510,2765,41934,1111.77
Trading Asset Securities
----231.78269.1
Cash & Short-Term Investments
16,46612,79013,69012,59343,63141,612
Cash Growth
-38.71%-6.57%8.72%-71.14%4.85%15.92%
Accounts Receivable
47,26044,96147,65648,76252,80358,678
Other Receivables
5,3823,9364,6804,7163,2976,241
Receivables
52,64248,89752,33653,47956,10164,945
Inventory
73,67059,87353,10848,38732,42348,590
Prepaid Expenses
341.11158.02186.42303.23515.3640.96
Other Current Assets
4,0353,6524,3393,6563,6716,707
Total Current Assets
147,154125,370123,659118,418136,340162,496
Property, Plant & Equipment
213,058216,421181,973178,244175,779185,966
Long-Term Investments
40,31143,51038,57252,84745,0292,513
Other Intangible Assets
1,7591,8881,8261,9352,0783,654
Long-Term Deferred Charges
23,78523,45325,53029,48134,39255,747
Other Long-Term Assets
26,69320,56821,04621,99125,64328,742
Total Assets
452,760431,211392,607402,916419,261439,117
Accounts Payable
25,62222,32226,30729,81323,71723,663
Accrued Expenses
450.95513.8398.44310.58314.19173.36
Short-Term Debt
88,80092,50565,78971,00092,50084,256
Current Portion of Long-Term Debt
2,500--2,000-18,485
Current Portion of Leases
341.38266.59522.11370.52159.24-
Current Income Taxes Payable
1,6981,2931,126958.543,5423,976
Other Current Liabilities
40,50640,00245,12140,87547,68746,594
Total Current Liabilities
159,918156,902139,263145,328167,920177,147
Long-Term Debt
27,50014,7006,000-5,000-
Long-Term Leases
334.95209.38339.24732.69843.73300.62
Pension & Post-Retirement Benefits
8,8348,5807,3227,9098,1368,785
Long-Term Deferred Tax Liabilities
8,3208,9349,23310,66210,4647,962
Other Long-Term Liabilities
403105050021.50
Total Liabilities
204,947189,635162,207165,132192,385194,195
Common Stock
47,71447,71447,71447,71447,71447,714
Additional Paid-In Capital
78,37078,37078,44178,41678,59078,795
Retained Earnings
70,77861,10153,55958,75943,17031,413
Treasury Stock
-12,269-11,269-11,921-10,075-7,437-7,743
Comprehensive Income & Other
58,31060,96657,95758,49660,58755,902
Total Common Equity
242,903236,881225,751233,311222,624206,081
Minority Interest
3,7983,5823,5363,3613,13937,728
Shareholders' Equity
247,813241,576230,400237,785226,876244,922
Total Liabilities & Equity
452,760431,211392,607402,916419,261439,117
Total Debt
119,476107,68172,65074,10398,503103,041
Net Cash (Debt)
-103,011-94,891-58,960-61,511-54,872-61,429
Net Cash Per Share
-5855.58-5280.07-3272.13-3393.60-3014.10-3374.26
Filing Date Shares Outstanding
17.9218.0117.9718.0918.2118.21
Total Common Shares Outstanding
17.9218.0117.9718.0918.2118.21
Working Capital
-12,764-31,532-15,604-26,910-31,580-14,651
Book Value Per Share
13551.0813150.2712561.4212899.4512228.6311319.92
Tangible Book Value
241,143234,994223,925231,375220,547202,427
Tangible Book Value Per Share
13452.9213045.4812459.7912792.4612114.4911119.20
Land
115,120120,507120,298120,308116,955102,083
Buildings
39,68841,12642,78744,47445,99557,001
Machinery
3,2704,0556,0609,3679,48014,843
Construction In Progress
54,38049,58311,4352,3841,95311,144
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.